ClinicalTrials.Veeva

Menu

Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers

Abbott logo

Abbott

Status

Completed

Conditions

Healthy

Treatments

Other: Sampling Rate

Study type

Observational

Funder types

Industry

Identifiers

NCT01126567
F09-113

Details and patient eligibility

About

The objective of this study is to determine the effects of cerebrospinal fluid sampling rate on biomarker levels of young, healthy volunteers.

Enrollment

8 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age is between 18 and 50 years, inclusive
  • Judged to be in general good health based on medical history, physical exam, neuro exam, vital signs, lab profile and ECG

Exclusion criteria

  • Positive urine drug screen for drugs of abuse
  • History of bleeding disorder or deep vein thrombosis
  • History of migraine or other types of headache more than twice/month, history of spinal disc disease or chronic significant low back pain
  • Use of blood thinning compounds within 10 days of lumbar drain placement
  • Finding on head CT that contraindicates lumbar puncture
  • History of spinal surgery
  • Use of tobacco/nicotine containing products within 6 month period prior to initial lumbar drain placement

Trial design

8 participants in 2 patient groups

High Sampling Rate
Description:
Samples will be obtained at a high rate
Treatment:
Other: Sampling Rate
Low Sampling Rate
Description:
Samples will be obtained at a low rate
Treatment:
Other: Sampling Rate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems